Month: September 2019

Huntington Ingalls Industries, Inc.’ s HII business division, Newport News, recently won a modification contract for the repair, maintenance, upgrade and modernization efforts for the USS Columbus (SSN 762) engineered overhaul. The deal has been awarded by the supervisor of shipbuilding, Conversion and Repair, Newport News, VA. Valued at $20 million, the contract is scheduled to be closed by November 2020 […]

Shares of Incyte Corporation INCY have gained 16% in the year so far against the industry ’s decline of 3.8%. The strong performance has been driven by the solid performance of the company’s lead drug, Jakafi, and encouraging pipeline progress in the year so far. […]

The Boeing Company ’s BA Defense, Space, and Security unit (BDS) recently secured a $280-million deal to provide engineering support to the Small Diameter Bomb (SDB) I weapon system. The contract was awarded by the Air Force Life Cycle Management Center, Eglin Air Force Base, FL. Per the terms, the BDS unit will provide SDB weapon integration on selected weapon platforms and support the fielded weapon system. […]

Actuant Corporation ATU reported fourth-quarter fiscal 2019 results (ended Aug 31, 2019), wherein earnings surpassed the Zacks Consensus Estimate by 16.67%. This was the company’s sixth consecutive quarter of earnings beat. However, revenues in the quarter missed the estimate by 6.15%. […]

Vail Resorts, Inc. MTN reported better-than-expected results in fourth-quarter fiscal 2019. […]

The property and casualty (P&C) insurance industry has lost 1.1% quarter to date against the Zacks S&P 500 composite’s increase of 1.1%. The Finance sector has also declined 0.9% in the said time frame. While cat losses weigh on underwriting profitability, low interest rate affects investment results of insurers. […]

TOTAL S.A. TOT has provided a long-term outlook, aiming to increase production by an average of 5% per year between 2018 and 2021. After a stable period between 2022 and 2023, growth will resume at more than 3% per year driven mainly by LNG project start-ups […]

American Airlines AAL provided details on the additional flights connecting Tokyo Haneda Airport with key U.S. destinations. The flights are scheduled to start operating from 2020 […]

McDonald’s Corp. MCD recently announced its three-month trial of a new plant-based burger P.L.T., (Plant. Lettuce. […]

FibroGen, Inc. FGEN announced that it has dosed the first patient in a phase II study on roxadustat for the treatment of chemotherapy-induced anemia (CIA) in cancer patients receiving chemotherapy, an area with highly unmet medical need. […]

Shares of Legg Mason LM have surged nearly 50.7% year to date as against the industry ’s decline of approximately 0.6%. Strong fundamentals driven by steady revenue growth as well as inorganic expansion strategy seem to be the primary reasons for this impressive stock performance. Further, this Zacks Rank #3 (Hold) stock has been witnessing solid estimate revisions […]

W.R. Berkley WRB is well-poised for growth, given its sturdy insurance business, growing international business, sound capital position and prudent capital deployment. […]

In a bid to popularize its virtual reality (VR) offerings among the masses, Facebook ’s FB Oculus virtual reality unit unveiled a host of features and updates on Sep 25 at the sixth Oculus Connect developer conference in San Jose, CA. Oculus Connect 6 focused on introduction of Facebook Horizon, a social VR world where users can design detailed individual avatars to interact and create their own spaces, including tropical hangout spots and interactive action arenas using World Builder, a collection of easy-to-use tools. […]

Nektar Therapeutics NKTR updated preliminary data from one cohort of the phase I/II PIVOT-02 study, evaluating its immuno-oncology candidate, bempegaldesleukin, in combination with Bristol-Myers’ BMY PD-1 inhibitor, Opdivo (nivoumab) in patients with advanced or metastatic triple-negative breast cancer (“TNBC”), came in below market expectations. The data was presented at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference held in France. […]

Exxon Mobil Corporation XOM recently announced a deal with Vår Energi AS to divest its Norwegian non-operated upstream assets. The transaction, likely to close in the December quarter of 2019, is valued at $4.5 billion. […]

Constant earnings growth captivates almost everyone, right from the top brass to research analysts. This is because earnings are a measure of the money a company is making. […]